Close Menu

NEW YORK (GenomeWeb) – As an assortment of companies leverage various technologies for infectious disease pathogen detection, one firm has adopted a deep-sequencing approach that its CEO said can identify a broad number of infectious disease pathogens to treat people with chronic medical conditions.

The highly multiplexed service, developed by Aperiomics, incorporates Bayesian statistical analysis, along with deep sequencing.

Get the full story with
360Dx Premium

Only $95 for the
first 90 days*

360Dx Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try 360Dx Premium now.

You may already have institutional access!

Check if I qualify.

Already a 360Dx or GenomeWeb Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.